Companies: 10,795·Total market cap: $144.5T
Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.

TERNNASDAQHealthcare
$52.95
$-0.02(-0.03%)
Market Cap$4.8B
P/E Ratio—
52W High$53.19
52W Low$2.655
Overview

Terns Pharmaceuticals, Inc. (TERN) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

TERN · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$1.02B▲ +184.5% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$524.7M
cashAndCashEquivalents
Short-Term Investments
$494.2M
shortTermInvestments
YoY Change vs Prior Year
+184.5%
vs prior fiscal year
Latest Quarter
$1.02B
Q4 2025
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$1.02BCash on Hand
Total Debt$919,000Total Debt
Net Cash / Net Debt+$1.02BNet Cash Position
Cash vs Debt Ratio
Cash 100%Debt 0%

Terns Pharmaceuticals, Inc. has a net cash position of $1.02B, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$1.02B − $919,000 = +$1.02B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
TERN annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$1.02B+184.5%
Dec 31, 2024$358.2M+36.0%
Dec 31, 2023$263.4M-6.9%
Dec 31, 2022$283.1M+70.6%
Dec 31, 2021$166.0M+121.7%
TERN cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Terns Pharmaceuticals, Inc.
Terns Pharmaceuticals, Inc.YOU
TERN
$1.02B21.4%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Terns Pharmaceuticals, Inc. (TERN) cash on hand as of December 31, 2025 is $1.02B, comprising $524.7M in cash and cash equivalents (CCE) plus $494.2M in short-term investments — reported as Terns Pharmaceuticals, Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Terns Pharmaceuticals, Inc. cash reserves or cash position.

Terns Pharmaceuticals, Inc. annual cash on hand history shows increased +184.5% in 2025: increased +184.5% in 2025. Terns Pharmaceuticals, Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Terns Pharmaceuticals, Inc. carries total debt of $919,000 against cash of $1.02B, resulting in a net cash position of +$1.02B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

TERN cash on hand · 5 questions

As of December 31, 2025, Terns Pharmaceuticals, Inc. (TERN) has $1.02B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $524,747,000 in cash and cash equivalents (CCE) plus $494,235,000 in short-term investments. Latest quarter (December 31, 2025): $1.02B. Data sourced from the annual 10-K filing via FMP.

TERN cash on handTERN cash reservesTERN cash 2025how much cash does TERN have

▸ Source: FMP /balance-sheet-statement · US GAAP · Terns Pharmaceuticals, Inc. · Terns Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025